Isabelle Demeestere
Overview
Explore the profile of Isabelle Demeestere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen T, Dutour R, Conrard L, Vermeersch M, Mirgaux M, Perez-Morga D, et al.
ACS Appl Bio Mater
. 2025 Mar;
PMID: 40089913
Nanoparticle technology, particularly gold nanoparticles (AuNPs), is being developed for a wide range of applications, including as a delivery system of peptides or nucleic acids (NA). Their use in precision...
2.
Azim Jr H, Niman S, Partridge A, Demeestere I, Ruggeri M, Gelber R, et al.
J Clin Oncol
. 2024 Sep;
42(34):4116-4117.
PMID: 39284115
No abstract available.
3.
Azim Jr H, Niman S, Partridge A, Demeestere I, Ruggeri M, Colleoni M, et al.
J Clin Oncol
. 2024 May;
42(23):2822-2832.
PMID: 38810178
Purpose: We investigated time to pregnancy, efficacy and safety of fertility preservation, and assisted reproductive technologies (ARTs) in women with early hormone receptor-positive breast cancer (BC) desiring future pregnancy. Patients...
4.
Erden M, Uyanik E, Demeestere I, Oktay K
Am J Obstet Gynecol
. 2024 Apr;
231(5):480-489.
PMID: 38621483
Objective: This study aimed to synthesize the existing evidence on perinatal outcomes after autologous cryopreserved ovarian tissue transplantation, concurrently identifying key factors influencing these outcomes. Data Sources: A comprehensive search...
5.
Klees C, Alexandri C, Demeestere I, Lybaert P
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203631
Oncological treatments have dramatically improved over the last decade, and as a result, survival rates for cancer patients have also improved. Quality of life, including concerns about fertility, has become...
6.
Dias Nunes J, Demeestere I, Devos M
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203374
Hereditary cancers mostly affect the adolescent and young adult population (AYA) at reproductive age. Mutations in () genes are responsible for the majority of cases of hereditary breast and ovarian...
7.
Nguyen T, Demeestere I
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38068916
Although effective in terms of the chances of future live birth, the current methods for fertility preservation, such as oocyte, embryo, or ovarian tissue cryopreservation, cannot be offered to all...
8.
Scavone G, Ottonello S, Blondeaux E, Arecco L, Scaruffi P, Stigliani S, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894292
The combination of cyclin-dependent kinase (CDK) 4/6 inhibitors with endocrine therapy is the standard treatment for patients with HR+/HER2- advanced breast cancer. Recently, this combination has also entered the early...
9.
Devos M, Dias Nunes J, Donfack Jiatsa N, Demeestere I
Sci Rep
. 2023 Sep;
13(1):15346.
PMID: 37714905
The Hippo pathway plays a crucial role in the regulation of follicular activation, which constitutes the first step of the folliculogenesis process. Disruption of this pathway occurs in several non-physiological...
10.
Prokurotaite E, Condorelli M, Dechene J, Bouziotis J, Lambertini M, Demeestere I
Life (Basel)
. 2023 Apr;
13(4).
PMID: 37109459
Background: Several studies have suggested that breast cancer (BC) and germline BRCA pathogenic variants (gBRCA PVs) could have a deleterious impact on ovarian reserve. Nevertheless, data are limited and mixed....